10760 J. Am. Chem. Soc., Vol. 122, No. 44, 2000
Wang et al.
2H); 13C NMR (400 MHz, CDCl3) δ 197.9, 144.5, 140.0, 139.7, 128.9,
128.5, 128.4, 128.4, 128.2, 127.3, 127.2, 126.9, 125.6, 54.3, 31.2, 28.9;
MS (EI, m/z, relative intensity), 300 (M+ + 2, 2.7), 299 (M+ + 1,
21.3), 298 (M+, 86.4), 207 (20.6), 194 (100.0), 166 (20.1), 165 (42.8);
HRMS C22H18O calcd 298.1358, found 298.1358. Anal. Calcd for
C22H18O: C, 88.56; H, 6.08. Found: C, 88.66; H, 6.22.
(3) 1-Cs (CsPhPAT) + HexBr or HexI. The solution was taken
out of box and carried out on GC-MS directly. Both reactions gave
only one product: 384 (M + 2, 3.28), 383 (M + 1, 21.60), 382 (M,
70.17), 367 (0.05), 354 (0.06), 353 (0.11), 311 (0.46), 305 (0.09), 299
(24.38), 298 (100.0), 297 (20.95), 278 (5.01), 269 (16.94), 221 (6.40),
207 (73.18).
2-Phenyl-1-tetralone, 2. A solution of n-BuLi (10 mL, 2.5 M in
hexane) was added to 3 mL of diisopropylamine in THF (20 mL) at
-78 C followed by 1.4 g of phenylacetic acid and then 1.6 mL of
â-phenylethyl bromide. The mixture was stirred at -78 C for 30 min
and was gradually allowed to warm to room temperature. The solution
was stirred for an additional 10 h. After pumping off the solvent, 100
mL of water was added to the residual yellow oil. After 2 weeks, yellow
crystals formed and the solid (0.6 g) was dried and cyclized by
following the procedure of Newman. After recrystallization from ethanol
and sublimation, 0.4 g of white solid was obtained: mp 73-74 °C
(4) 1-Li (LiPhPAT) + BnBr. Only one product was found on GC-
MS: 389 (M + 1, 22.0), 388 (M, 89.3), 310 (5.7), 298 (14.7), 297
(68.4), 269 (100.0), 194 (38.0).
(5) 1-Li (LiPhPAT) + 2-ClBnBr. The reaction was carried out on
a preparative scale. A vial containing 5.295 mg of LDA and 5.40 g of
THF was shaken and 14.7 mg of PhPAT was added. The solution was
left in the glovebox for 2 days to complete the formation of LiPhPAT.
Then 21.0 µL of 2-ClBnBr was added and the solution was mixed.
After 1 week in the glovebox the solution was quenched with 1 drop
of water. GC-MS showed only one product identified as that of
C-alkylation. Solvent was removed, and the residue was purified on
preparative TLC to give 21.0 mg of product; MS (m/z, relative
intensity), 424 (M + 2, 0.65), 423 (M + 1, 0.52), 422 (M, 1.80), 389
(5.44), 388 (32.30), 387 (100.0), 386 (3.42), 345 (0.62), 310 (0.56),
309 (0.72), 298 (8.45), 297 (32.73), 296 (6.73), 270 (11.99), 269 (52.19),
194 (22.80); HRMS C29H2335ClO calcd 422.1437, found 422.1445;
1
(lit.37,38 76-77 °C); H NMR δ (300 MHz) 8.1 (1 H, d), 7.5 (1 H),
7.4-7.2 (7 H), 3.8 (1 H), 3.1 (2 H), 2.45 (2 H); m/z 222.
Kinetic Studies. The enolate solutions were prepared as in the
spectral studies, and known amounts of the alkyl halide or sulfonate
were added. Excess alkylating agent was used to give pseudo-first-
order conditions. The resulting kinetic solutions generally contained
0.0002-0.001 M enolate and 0.006-0.04 M alkylating agent. The
enolate absorption was followed for 10-20% of the reaction, and the
resulting linear relation with time was used as the initial rate of reaction.
The kinetic results are shown graphically in the Supporting Information,
and the rate constants are summarized in Tables 2 and 3.
Product Analyses. The reaction mixtures were allowed to run to
completion in the glovebox and analyzed by GC-MS (MS given as
m/z, relative intensity).
(1) 1-Cs (CsPhPAT) + MeOTs: both C- and O-products, C/O )
1.0/2.0. 2-MePhPAT (C-alkylation), 314 (M + 2, 0.9), 313 (M + 1,
6.3), 312 (M, 25.2), 207 (10.4), 195 (15.3), 194 (100.0), 165 (53.2).
O-MePhPAT (O-alkylation), 314 (M + 2, 3.3), 313 (M + 1, 26.3),
312 (M, 100.0), 310 (2.4), 297 (3.7), 296 (4.7), 281 (8.5), 269 (11.8),
235 (5.7), 222 (8.2), 221 (45.9).
1
C29H2337ClO calcd 424.1408, found 424.1421; H NMR (400 MHz,
CDCl3) δ (ppm) 8.26 (d, J ) 8.22 Hz, 1H), 7.51 (t-d, J1 ) 6.98 Hz,
J2 ) 1.45 Hz, 3H), 7.41 (t-d, J1 ) 7.78 Hz, J2 ) 1.95 Hz, 2H), 7.36-
7.30 (multi, 2H), 7.28-7.22 (multi, 5H), 7.10 (t-d, J1 ) 7.41 Hz, J2
) 1.67 Hz, 1H), 7.02 (t-d, J1 ) 7.51 Hz, J2 ) 1.27 Hz, 1H), 6.88
(d-d, J1 ) 7.68 Hz, J2 ) 1.66 Hz, 1H), 3.69 (d, J ) 13.78 Hz, 1H),
3.44 (d, J ) 13.78 Hz, 1H), 2.88 (t-d, J1 ) 17.02 Hz, J2 ) 4.12 Hz,
1H), 2.81-2.75 (multi, 2H), 2.29 (t-d, J1 ) 13.06 Hz, J2 ) 4.89 Hz,
1H); 13C NMR (400 MHz, CDCl3) δ (ppm) 199.1, 145.8, 143.8, 139.9,
138.7, 135.8, 135.7, 133.0, 131.6, 129.3, 128.8, 128.8, 128.5, 128.1,
127.6, 127.4, 127.2, 127.1, 127.0, 126.2, 125.4, 55.9, 41.5, 30.2, 25.8.
Acknowledgment. This work was supported in part by NIH
Grant GM-30369 and NSF Grant 9980367.
(2) 1-Cs (CsPhPAT) + MeOBs: both C- and O-products, C/O )
1.0/3.2).
Supporting Information Available: Additional tables and
figures. This material is available free of charge via the Internet
(37) Newman, M. S. J. Am. Chem. Soc. 1938, 60, 2847.
(38) Newman, M. S. J. Am. Chem. Soc. 1940, 62, 870.
(39) Gareyev, R.; Ciula, J. C.; Streitwieser, A. J. Org. Chem. 1996, 61,
4589-93.
JA0010002